- Report
- January 2026
- 184 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- June 2025
- 90 Pages
Global
From €3500EUR$4,281USD£3,144GBP
- Report
- February 2026
- 50 Pages
Global
From €2321EUR$2,650USD£2,014GBP
- Report
- January 2026
- 181 Pages
Global
From €3941EUR$4,500USD£3,421GBP
- Report
- January 2026
- 191 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- September 2025
- 250 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- April 2025
- 200 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- April 2025
- 200 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- February 2025
- 200 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- April 2025
- 185 Pages
Global
From €3941EUR$4,500USD£3,421GBP
- Report
- April 2023
- 175 Pages
Global
From €5166EUR$5,899USD£4,484GBP
- Report
- January 2024
- 269 Pages
Global
From €6536EUR$7,724USD£5,481GBP
- Report
- November 2021
- 220 Pages
Global
From €2102EUR$2,400USD£1,824GBP
- Report
- January 2024
- 200 Pages
Global
From €3635EUR$4,150USD£3,155GBP
- Report
- July 2024
- 100 Pages
Global
From €3284EUR$3,750USD£2,851GBP
- Report
- September 2025
- 70 Pages
India
From €3065EUR$3,500USD£2,661GBP
- Report
- September 2025
- 88 Pages
India
From €3065EUR$3,500USD£2,661GBP
- Report
- April 2025
- 85 Pages
Saudi Arabia
From €3065EUR$3,500USD£2,661GBP
From €3065EUR$3,500USD£2,661GBP
- Report
- February 2024
- 150 Pages
Global
From €4160EUR$4,750USD£3,611GBP

Azithromycin is an antibiotic used to treat a wide range of bacterial infections. It is a macrolide-type antibiotic, which works by stopping the growth of bacteria. Azithromycin is commonly used to treat respiratory infections, skin infections, ear infections, and sexually transmitted diseases. It is also used to prevent certain bacterial infections in people with weakened immune systems. Azithromycin is available in both oral and intravenous forms, and is often prescribed in combination with other antibiotics.
Azithromycin is one of the most widely prescribed antibiotics in the world. It is generally well-tolerated and has a low risk of side effects. It is also relatively inexpensive, making it an attractive option for many patients.
The azithromycin market is highly competitive, with many companies offering generic versions of the drug. Some of the major players in the market include Pfizer, Merck, GlaxoSmithKline, Sanofi, and Novartis. Show Less Read more